Source: Eur Respir J 2007; 30: 1167-1172
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Sibila O., Agusti C., Torres A., Baquero S., Gando S., Patron J. R., Morato J. G., Goffredo D. H., Bassi N., Luna C. M.. Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response. Eur Respir J 2007; 30: 1167-1172

Member's Comments

No comment yet.

Related content which might interest you: Effects of glucocorticoids in ventilated piglets with severe pneumonia Source: Eur Respir J 2008; 32: 1037-1046 Year: 2008 Novel swine ARDS model induced by Pseudomonas aeruginosa pneumonia and VILI Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020 Animal models of VAP Source: Eur Respir Mon 2011; 53: 98-112 Year: 2011 Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model Source: Eur Respir J 2007; 29: 965-968 Year: 2007 Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa Source: Eur Respir J 2003; 22: 503-506 Year: 2003 In vivo evidence for aspergillus fumigatus and pseudomonas aeruginosa driven th-17 type inflammatory responses in the lungs of CF-patients Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Pseudomonas aeruginosa infections Source: Respipedia Article Year: 2018 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis Source: Eur Respir J 2006; 28: 974-979 Year: 2006 Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73 Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Osteopontin promotes host defense during Klebsiella pneumoniae-induced pneumonia Source: Eur Respir J 2010; 36: 1337-1345 Year: 2010 Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017 Early mortality in patients with community-acquired pneumonia: causes and risk factors Source: Eur Respir J 2008; 32: 733-739 Year: 2008 Comparison between two protocols of preventing treatment of chronic Pseudomonas aeruginosa (Pa) infection Source: Eur Respir J 2005; 26: Suppl. 49, 620s Year: 2005 Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 The impact of time on the systemic inflammatory response in pneumococcal pneumonia Source: Eur Respir J 2010; 35: 614-618 Year: 2010 Chronic bronchial infection/colonisation: aetiology and mechanisms Source: Eur Respir Monogr 2013; 60: 34-45 Year: 2013 Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors Source: Eur Respir J 2010; 35: 598-615 Year: 2010 Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis Source: Eur Respir J 2005; 26: 651-656 Year: 2005 ExoU-induced procoagulant activity in Pseudomonas aeruginosa-infected airway cells Source: Eur Respir J 2008; 32: 1591-1598 Year: 2008